Watch our live company presentation with NanoEcho’s CEO

Did you miss our live company presentation with NanoEcho’s CEO, Linda Persson, yesterday? No worries, you can watch it afterwards. The presentation is now also subtitled.

NanoEcho is currently conducting a new share issue to enter the clinical phase with our patented diagnostic method. The goal is to improve healthcare by providing patients with rectal cancer a more accurate diagnosis and personalised treatment.

Learn more about the ongoing share issue:

Pågående emission
i NanoEcho

Erbjudande om att teckna aktier i NanoEcho AB (publ) i samband med IPO
Teckningstid: 29 maj – 28 juni

We use cookies to enhance your experience on our website and analyze our traffic. By clicking ‘Accept,’ you consent to our use of cookies. You can learn more about the types of cookies we use and how to manage them in our privacy policy.